English   Danish

2024/2025  KAN-CBIOO1009U  Innovation Challenges in BioBusiness

English Title
Innovation Challenges in BioBusiness

Course information

Language English
Course ECTS 7.5 ECTS
Type Mandatory (also offered as elective)
Level Full Degree Master
Duration One Quarter
Start time of the course Second Quarter
Timetable Course schedule will be posted at calendar.cbs.dk
Max. participants 50
Study board
Study Board for MSc. in Business Administration and Bioentrepreneurship
Course coordinator
  • Markus Simeth - Department of Strategy and Innovation (SI)
Main academic disciplines
  • Innovation
  • Strategy
Teaching methods
  • Blended learning
Last updated on 26-01-2024

Relevant links

Learning objectives
Following the completion of this course, students should be able to:
  • Account for the main innovation-related terms and taxonomies
  • Evaluate the potential for internal and external knowledge sourcing and how it may help the organization in its pursuit of innovation
  • Make informed choices with respect to alternative R&D projects
  • Reflect on how companies can effectively manage highly creative and skilled R&D personnel
  • Formulate innovation based strategies in high-technology settings and account for their use
  • Understand the role of institutions (universities, intellectual property, financial markets) in the innovation process
  • Acquire professional skills in strategy formulation and innovation management
Course prerequisites
This is a mandatory course for the MSc in Business Administration and Bioentrepreneurship.

To sign up send a 1-page motivational letter and a grade transcript to ily.stu@cbs.dk before the CBS registration deadline for elective courses. You may find the registration deadlines on my.cbs.dk ( https:/​​/​​studentcbs.sharepoint.com/​​graduate/​​pages/​​registration-for-electives.aspx ). Please also remember to sign up through the online registration.
Examination
Innovation Challenges in BioBusiness:
Exam ECTS 7,5
Examination form Written sit-in exam on CBS' computers
Individual or group exam Individual exam
Assignment type Written assignment
Duration 4 hours
Grading scale 7-point grading scale
Examiner(s) One internal examiner
Exam period Autumn
Aids Limited aids, see the list below:
The student is allowed to bring
  • An approved calculator. Only the models HP10bll+ or Texas BA ll Plus are allowed (both models are non-programmable, financial calculators).
  • Language dictionaries in paper format
The student will have access to
  • Advanced IT application package
Make-up exam/re-exam
Same examination form as the ordinary exam
The number of registered candidates for the make-up examination/re-take examination may warrant that it most appropriately be held as an oral examination. The programme office will inform the students if the make-up examination/re-take examination instead is held as an oral examination including a second examiner or external examiner.
.
Course content, structure and pedagogical approach

The course will provide a comprehensive introduction to innovation management with focus on the biotech and pharma sectors. Students will learn about alternative innovation related strategies that can be employed for obtaining competitive advantage. Students will develop an awareness regarding key trade-offs and tensions for strategic decision making in the innovation context. The course will be structured around managerial challenges that firms face in the biotech, pharmaceutical and medical equipment sectors. Students will work individually and in teams on in-class assignments that focus on specific innovation-related challenges.

 

The course will cover the following topics:

 

  • Strategy and business conduct of firms in the biotech and pharma sectors
  • The role of institutions in the innovation process (e.g. universities, intellectual property rights)
  • Corporate R&D and scientific research
  • Appropriability mechanisms
  • Sourcing of external innovation, open innovation, and markets for technology
  • Organizing for Innovation
  • The link between financial markets and corporate innovation
  • Artificial intelligence and IT in the life sciences
  • Applied frameworks for new product development
Description of the teaching methods
Teaching includes lecture-style classes, in-class workshops with students presenting and actively participating in discussions around pre-assigned cases and/or exercises, and guest presentations by academics and practitioners. This course will be offered in a blended learning format, both in-class and online. Online session can be either pre-recorded or live, or a combination of the two. Preparation before class is of crucial importance. The course integrates the Nordic 9 principles both in the content and the teaching methods.
Feedback during the teaching period
Feedback is given through the quizzes online and in class. Additionally, one session is dedicated to a mock-exam, followed by peer-grading and feedback from the lecturer. Students are encouraged to make use of office/consultation hours.
Student workload
lecture 40 hours
preparation 166 hours
Expected literature
  • Porter, M.E., 1996. What is strategy?. Harvard business review74(6), pp.61-78.
  • Teece D.J. 1986. Profiting from technological innovation: Implications for integration collaboration, licensing and public policy. Research Policy 15, 285-305
  • Cockburn, I.M. and Henderson, R.M. (1998). Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. Journal of Industrial Economics, 46(2), 157–182.
  • Perkmann, M., et al. (2013). Academic engagement and commercialisation: A review of the literature on university–industry relations. Research Policy 42(2) 423-442.

 

 

Additional literature will be announced in the course syllabus.

Last updated on 26-01-2024